TABLE 2.
Triptan dosing and efficacy in acute VM attack.
| Abortive therapy | ||||
|---|---|---|---|---|
| Medication | Dose | Study | Study type | Effect found |
| Almotriptan | 12.5 mg PO within 1 hour of attack | Cassano et al. | Retrospective, multicenter open‐label (n = 18) | 55% complete vertigo resolution, 28% of patients reported over 50% reduction of vertigo |
| Sumatriptan | Unspecified | Bikhazi et al. | Retrospective survey (n = 111) | Excellent efficacy at improving headaches (4) and vertigo (3) on a numerical scale from 1 to 4 |
| Zolmitriptan | 2.5 mg PO during attack | Neuhauser et al. | RCT (n = 10) | 38% of patients had improvement in vertigo at 2 hours following treatment versus 22% for placebo, results inconclusive due to limited power |